| 1 |
34377158 | IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer. | 2021 |
2 |
| 2 |
32279102 | Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine. | 2020 May |
1 |
| 3 |
33114161 | Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis. | 2020 Oct 23 |
1 |
| 4 |
31114380 | Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma. | 2019 |
1 |
| 5 |
32655287 | Understanding the Mechanism of Cell Death in Gemcitabine Resistant Pancreatic Ductal Adenocarcinoma: A Systems Biology Approach. | 2019 Nov |
1 |
| 6 |
26179201 | Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. | 2015 Aug |
1 |
| 7 |
24201777 | Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. | 2014 Jan |
1 |
| 8 |
24713296 | Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer. | 2014 Apr 9 |
1 |
| 9 |
24864163 | Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review. | 2014 |
1 |
| 10 |
23579097 | BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents. | 2013 Jul |
1 |
| 11 |
21424698 | A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer. | 2012 Jun |
1 |
| 12 |
21706279 | Different combination schedules of gemcitabine with endostar affect antitumor efficacy. | 2012 Jan |
3 |
| 13 |
21757252 | The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine. | 2012 Feb |
1 |
| 14 |
21839751 | CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. | 2011 Oct 24 |
4 |
| 15 |
20118543 | Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gene in human pancreatic cancer cells. | 2010 |
3 |
| 16 |
20739850 | HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients. | 2010 Sep |
2 |
| 17 |
22993609 | Gemcitabine and paclitaxel suppress the production of vascular endothelial growth factor induced by deferoxamine in human non-small cell lung cancer A549 cells. | 2010 Sep |
2 |
| 18 |
16972327 | Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine. | 2006 Oct |
1 |
| 19 |
15947684 | Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and Cisplatin. | 2005 Jul |
2 |
| 20 |
16101140 | Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy. | 2005 Sep-Oct |
2 |
| 21 |
14654905 | Gemcitabine suppresses malignant ascites of human pancreatic cancer: correlation with VEGF expression in ascites. | 2004 Jan |
5 |
| 22 |
11836671 | The role of gemcitabine in the treatment of malignant mesothelioma. | 2002 Feb |
2 |
| 23 |
12385004 | Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice. | 2002 Nov 10 |
2 |
| 24 |
10815919 | Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. | 2000 May |
2 |